These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 1916652)

  • 1. Evidence of altered dopaminergic modulation of prolactin and thyrotropin secretion in patients with polycystic ovary syndrome.
    Velardo A; Pantaleoni M; Zironi C; Zizzo G; Marrama P
    Horm Res; 1991; 35(1):4-7. PubMed ID: 1916652
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Evaluation of dopaminergic activity of the hypothalamus in patients with polycystic ovarian syndrome].
    Zironi C; Pantaleoni M; Zizzo G; Coletta F; Velardo A
    Minerva Ginecol; 1991 Oct; 43(10):443-7. PubMed ID: 1685015
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypothalamic dopaminergic tone and prolactin bioactivity in women with polycystic ovary syndrome.
    Hernández I; Parra A; Méndez I; Cabrera V; Cravioto MC; Mercado M; Díaz-Sánchez V; Larrea F
    Arch Med Res; 2000; 31(2):216-22. PubMed ID: 10880731
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence that an altered prolactin release is consequent to abnormal ovarian activity in polycystic ovary syndrome.
    Paoletti AM; Cagnacci A; Soldani R; Orrù M; Ajossa S; Pittorra G; Mulas P; Melis GB
    Fertil Steril; 1995 Dec; 64(6):1094-8. PubMed ID: 7589658
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The acute effects of a dopamine antagonist (domperidone) on luteinising hormone, follicule stimulating hormone, prolactin and thyrotrophin secretion in polycystic ovarian syndrome: differential effect of ovulation.
    Murdoch AP; Dunlop W; Kendall-Taylor P; Watson MJ
    Clin Endocrinol (Oxf); 1984 Dec; 21(6):611-9. PubMed ID: 6439439
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metoclopramide effect on serum prolactin LH and FSH in patients with polycystic ovary syndrome.
    Prelević GM; Würzburger MI; Perić LA
    J Endocrinol Invest; 1988 Apr; 11(4):255-9. PubMed ID: 3137253
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The interrelationships between prolactin and thyrotrophin secretion following dopaminergic blockage in patients with mild hyperprolactinaemia without any demonstrable pituitary tumour.
    Spitz IM; Haas M; Trestian S; Zylber-Haran E; Shilo S
    Clin Endocrinol (Oxf); 1983 Sep; 19(3):285-94. PubMed ID: 6414745
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dopamine might not be involved in the pathogenesis of polycystic ovary syndrome.
    Ferriani RA; Silva de Sá MF; Moura MD; Moreira AC; Gomes UA
    Gynecol Endocrinol; 1989 Dec; 3(4):317-27. PubMed ID: 2516707
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence of altered dopaminergic modulation of Prl, LH and TSH secretion in patients with normoprolactinaemic amenorrhoea.
    Hagen C; Petersen K; Djursing H; Andersen AN
    Acta Endocrinol (Copenh); 1984 May; 106(1):8-14. PubMed ID: 6428118
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence for dopamine-related and TRH-related pituitary TSH and PRL pools in patients with prolactinoma.
    Hanew K; Utsumi A; Sugawara A; Shimizu Y; Yoshinaga K
    Acta Endocrinol (Copenh); 1991 May; 124(5):545-52. PubMed ID: 1903012
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evening not morning plasma cortisol level is higher in women with polycystic ovary syndrome.
    Kiałka M; Ociepka A; Milewicz T; Krzyczkowska-Sendrakowska M; Gosztyła K; Stochmal E; Lurzyńska M; Bałajewicz-Nowak M
    Przegl Lek; 2015; 72(5):240-2. PubMed ID: 26817325
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Daytime decrease of prolactin levels is associated with PCOS regardless to nutritional status and other hormones levels.
    Franik G; Madej P; Guz-Lem M; Owczarek A; Chudek J; Olszanecka-Glinianowicz M
    Gynecol Endocrinol; 2017 May; 33(5):336-341. PubMed ID: 28277129
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prolactin release in polycystic ovary.
    Falaschi P; del Pozo E; Rocco A; Toscano V; Petrangeli E; Pompei P; Frajese G
    Obstet Gynecol; 1980 May; 55(5):579-82. PubMed ID: 6768043
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elevated serum levels of anti-Müllerian hormone can be introduced as a new diagnostic marker for polycystic ovary syndrome.
    Sahmay S; Atakul N; Aydogan B; Aydin Y; Imamoglu M; Seyisoglu H
    Acta Obstet Gynecol Scand; 2013 Dec; 92(12):1369-74. PubMed ID: 23980726
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced hypothalamic dopaminergic inhibition of LH, TSH and GH release in patients with pathological hyperprolactinaemia.
    Ho KY; Smythe GA; Lazarus L
    Acta Endocrinol (Copenh); 1985 Mar; 108(3):289-96. PubMed ID: 3984660
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metastin levels in relation with hormonal and metabolic profile in patients with polycystic ovary syndrome.
    Yilmaz SA; Kerimoglu OS; Pekin AT; Incesu F; Dogan NU; Celik C; Unlu A
    Eur J Obstet Gynecol Reprod Biol; 2014 Sep; 180():56-60. PubMed ID: 25020276
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence for endogenous dopaminergic regulation of thyrotropin (TSH) secretion in man.
    Sasaki A; Hanew K; Sato S; Yoshinaga K
    Tohoku J Exp Med; 1983 Jan; 139(1):1-7. PubMed ID: 6836556
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prolactin secretion in polycystic ovary syndrome (PCO): correlation with the steroid pattern.
    Carmina E; Rosato F; Maggiore M; Gagliano AM; Indovina D; Jannì A
    Acta Endocrinol (Copenh); 1984 Jan; 105(1):99-104. PubMed ID: 6229966
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum visfatin, vascular endothelial growth factor and matrix metalloproteinase-9 in women with polycystic ovary syndrome.
    Dambala K; Vavilis D; Bili E; Goulis DG; Tarlatzis BC
    Gynecol Endocrinol; 2017 Jul; 33(7):529-533. PubMed ID: 28300464
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute endocrine profile of sulpiride in the human.
    L'Hermite M; Denayer P; Golstein J; Virasoro E; Vanhaelst L; Copinschi G; Robyn C
    Clin Endocrinol (Oxf); 1978 Sep; 9(3):195-204. PubMed ID: 709890
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.